• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Two-dimensional contrast echocardiography. II. Transpulmonary studies.

作者信息

Ten Cate F J, Feinstein S, Zwehl W, Meerbaum S, Fishbein M, Shah P M, Corday E

出版信息

J Am Coll Cardiol. 1984 Jan;3(1):21-7. doi: 10.1016/s0735-1097(84)80425-8.

DOI:10.1016/s0735-1097(84)80425-8
PMID:6690551
Abstract

A method using contrast two-dimensional echocardiography for left ventricular chamber and myocardial opacification from a right-sided pulmonary capillary wedge position is described. A total of 152 studies were carried out in nine mongrel dogs. Four different catheters with different catheter tip cross-sectional areas (varying from 0.75 to 2.3 mm2) were used. In addition, catheter position (six different positions in the pulmonary circulation), pressure of injection and type of echo contrast agent (hand-agitated and sonicated) were studied. In all 152 studies, two independent observers agreed that echo contrast was seen in the left ventricular chamber after a pulmonary capillary wedge injection of 8 cc of echo contrast agent followed by a flush injection of 8 cc saline solution. In 71% of the studies, the two independent observers agreed about the degree of opacification on a qualitative scale of 0 to 3+. Time from injection from the catheter tip to the appearance of echo contrast in the left atrium was 6.2 +/- 4.8 seconds for sonicated Renografin-76 and 2.8 +/- 0.6 seconds for sonicated sorbitol 70% (p less than 0.05). Correlation for the disappearance rate of echo contrast as determined for the region in the mid left ventricular chamber and thermodilution cardiac output was fair (r = -0.78; n = 14). In 24 studies, it was not possible to demonstrate the appearance of echo contrast in the myocardium. Peak videointensity of 10 duplicate injections showed a mean percent error of 10.4 +/- 2.1% for sonicated Renografin-76 and 1.4 +/- 0.8% for sonicated sorbitol 70%.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Two-dimensional contrast echocardiography. II. Transpulmonary studies.
J Am Coll Cardiol. 1984 Jan;3(1):21-7. doi: 10.1016/s0735-1097(84)80425-8.
2
Factors affecting penetration of retrograde coronary venous injections into normal and ischemic canine myocardium: assessment by contrast echocardiography and digital angiography.影响逆行冠状动脉静脉注射药物进入正常和缺血犬心肌的因素:通过对比超声心动图和数字血管造影进行评估
Basic Res Cardiol. 1990 Jan-Feb;85(1):21-32. doi: 10.1007/BF01907011.
3
Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility.冠状动脉内注射超声处理的微泡对左心室收缩性的影响。
Am J Cardiol. 1987 Jul 1;60(1):166-71. doi: 10.1016/0002-9149(87)91006-x.
4
Retrograde coronary venous contrast echocardiography: assessment of shunting and delineation of regional myocardium in the normal and ischemic canine heart.逆行冠状静脉造影超声心动图:正常和缺血犬心脏中分流的评估及局部心肌的描绘
J Am Coll Cardiol. 1984 Sep;4(3):577-86. doi: 10.1016/s0735-1097(84)80105-9.
5
Echocardiographic contrast agents: effect of microbubbles and carrier solutions on left ventricular contractility.超声心动图造影剂:微泡和载体溶液对左心室收缩性的影响
J Am Coll Cardiol. 1987 Apr;9(4):910-9. doi: 10.1016/s0735-1097(87)80250-4.
6
Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients.一种新型经肺超声造影剂在患者超声心动图研究中的安全性和有效性。
J Am Coll Cardiol. 1993 Oct;22(4):1193-8. doi: 10.1016/0735-1097(93)90437-6.
7
Left heart opacification with peripheral venous injection of a new saccharide echo contrast agent in dogs.
J Am Coll Cardiol. 1989 Jun;13(7):1622-8. doi: 10.1016/0735-1097(89)90357-4.
8
Hyperemic response of intracoronary contrast agents during two-dimensional echographic delineation of regional myocardium.
J Am Coll Cardiol. 1984 Jul;4(1):149-56. doi: 10.1016/s0735-1097(84)80333-2.
9
Myocardial contrast echocardiography in humans: I. Safety--a comparison with routine coronary arteriography.人体心肌对比超声心动图:I. 安全性——与常规冠状动脉造影的比较。
J Am Coll Cardiol. 1986 Nov;8(5):1066-72. doi: 10.1016/s0735-1097(86)80383-7.
10
Myocardial risk area and peak gray level measurement by contrast echocardiography: effect of microbubble size and concentration, injection rate, and coronary vasodilation.通过对比超声心动图测量心肌风险区域和峰值灰度水平:微泡大小和浓度、注射速率及冠状动脉扩张的影响
Am Heart J. 1988 Apr;115(4):733-9. doi: 10.1016/0002-8703(88)90872-1.

引用本文的文献

1
Current status and prospects for microbubbles in ultrasound theranostics.超声治疗中的微泡现状与展望。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Jul-Aug;5(4):329-45. doi: 10.1002/wnan.1219. Epub 2013 Mar 15.
2
Intravascular targets for molecular contrast-enhanced ultrasound imaging.分子对比增强超声成像的血管内靶点
Int J Mol Sci. 2012;13(6):6679-6697. doi: 10.3390/ijms13066679. Epub 2012 Jun 1.
3
Microbubbles in ultrasound-triggered drug and gene delivery.超声触发药物和基因递送中的微泡
Adv Drug Deliv Rev. 2008 Jun 30;60(10):1153-66. doi: 10.1016/j.addr.2008.03.005. Epub 2008 Apr 3.
4
Reproducibility of stress echocardiography using intravenous injection of ultrasound contrast agent (BY 963).
Int J Card Imaging. 1997 Oct;13(5):387-94. doi: 10.1023/a:1005822920962.
5
Contrast echocardiography for assessment of myocardial perfusion.用于评估心肌灌注的对比超声心动图。
Herz. 1997 Feb;22(1):40-50. doi: 10.1007/BF03044569.
6
Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.一种新型静脉超声造影剂(BY 963)与Albunex用于左心室腔显影的比较。
Basic Res Cardiol. 1996 Jan-Feb;91(1):101-9. doi: 10.1007/BF00788871.
7
Sonicated X-ray contrast agents for quantitative myocardial contrast echocardiography--a critical approach.用于定量心肌对比超声心动图的超声处理X射线造影剂——一种关键方法。
Heart Vessels. 1995;10(2):96-105. doi: 10.1007/BF01744500.
8
Quantitation in echocardiography.超声心动图中的定量分析。
Cardiovasc Intervent Radiol. 1987;10(6):316-31. doi: 10.1007/BF02577343.